Jacobs Levy Equity Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-250,724
| Closed | -$5.09M | – | 1121 |
|
|
2017
Q3 | $5.09M | Buy |
250,724
+128,459
| +105% | +$2.61M | 0.1% | 255 |
|
|
2017
Q2 | $1.97M | Sell |
122,265
-60,450
| -33% | -$973K | 0.04% | 430 |
|
|
2017
Q1 | $2.31M | Sell |
182,715
-2,300
| -1% | -$29.1K | 0.05% | 393 |
|
|
2016
Q4 | $2.45M | Sell |
185,015
-34,815
| -16% | -$461K | 0.05% | 381 |
|
|
2016
Q3 | $5.21M | Buy |
+219,830
| New | +$5.21M | 0.09% | 262 |
|
|
2014
Q3 | – | Sell |
-69,721
| Closed | -$2.09M | – | 960 |
|
|
2014
Q2 | $2.09M | Buy |
69,721
+47,220
| +210% | +$1.42M | 0.03% | 396 |
|
|
2014
Q1 | $594K | Sell |
22,501
-82,608
| -79% | -$2.18M | 0.01% | 638 |
|
|
2013
Q4 | $2.64M | Buy |
105,109
+57,310
| +120% | +$1.44M | 0.04% | 384 |
|
|
2013
Q3 | $978K | Buy |
+47,799
| New | +$978K | 0.02% | 537 |
|